Michael Hallett
Affiliations: | McGill University, Montreal, QC, Canada |
Area:
PhilosophyGoogle:
"Michael Hallett"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gruosso T, Gigoux M, Bertos N, et al. (2018) Abstract PD6-05: Distinct tumor microenvironments stratify triple negative breast cancer into immune subtypes Cancer Research. 78 |
Dumeaux V, Fjukstad B, Fjosne HE, et al. (2017) Interactions between the tumor and the blood systemic response of breast cancer patients. Plos Computational Biology. 13: e1005680 |
Liu H, Dowdle JA, Khurshid S, et al. (2017) Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation. Developmental Cell. 41: 392-407.e6 |
Lesurf R, Aure MR, Mørk HH, et al. (2016) Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer. Cell Reports |
Turpin J, Ling C, Crosby EJ, et al. (2016) The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene |
Cyr-Depauw C, Northey JJ, Tabariès S, et al. (2016) Chordin-like 1 suppresses BMP4-induced breast cancer cell migration and invasion. Molecular and Cellular Biology |
Boulay PL, Mitchell L, Turpin J, et al. (2016) Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression. Cancer Research |
Saleh S, Gruosso T, Gigoux M, et al. (2016) Abstract IA23: Deconvolution of the triple-negative breast cancer microenvironment Cancer Research. 76 |
Gruosso T, Gigoux M, Bertos N, et al. (2016) Abstract A15: Mechanisms of CD8+ T cell immunosuppression in triple negative breast cancer Cancer Research. 76 |
Hosein AN, Livingstone J, Buchanan M, et al. (2015) A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer. Bmc Cancer. 15: 130 |